Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma.

Background: In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1-3 therapy lines, newer agents demonstrated improved outcomes versus older agents. Real-world treatment pattern data are limited. We assessed real-world treatment patterns and outcomes in patients with RRMM (≥2 prior therapy lines).

Adherence to medications by patients after acute coronary syndromes.

Background: Nonadherence to medication may lead to poor medical outcomes.

Objective: To describe medication-taking behavior of patients with a history of acute coronary syndromes (ACS) for 4 classes of drugs and determine the relationship between self-reported adherence and patient characteristics.

Methods: Consenting patients with the diagnosis of ACS were interviewed by telephone approximately 10 months after discharge.